Author Question: In a terrorist attack, which period of time poses the greatest chance for inhalation of aerosolized ... (Read 76 times)

james

  • Hero Member
  • *****
  • Posts: 573
In a terrorist attack, which period of time poses the greatest chance for inhalation of aerosolized anthrax?
 
  a. The day of the attack
  b. The day after the attack
  c. 2 days after the attack
  d. 1 week after the attack

Question 2

Why is a chelating agent administered after a person has been exposed to particulate radioactive material?
 
  a. To bind with radioactive material and al-low it to be excreted
  b. To reduce radioactivity to nonharmful le-vels
  c. To form a protective coat in the gastroin-testinal system
  d. To dissolve particulate material



lgoldst9

  • Sr. Member
  • ****
  • Posts: 372
Answer to Question 1

B
Anthrax in an aerosolized form is most potent 1 day after the explosion. After that time, the or-ganism dies very quickly and anthrax is not communicable from person to person.

Answer to Question 2

A
Chelating agents bind with radioactive material, allowing it to be excreted without absorption.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library